Open AccessEffectiveness and safety analysis of rituximab in 146 Indian pemphigus patients: A retrospective single-center review of up to 68 months follow-up
Author(s) -
Dipankar De,
Anuradha Bishnoi,
Sanjeev Handa,
Tanmay Mahapatra,
Rahul Mahajan
Publication year - 2019
Publication title -
indian journal of dermatology venereology and leprology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.514
H-Index - 45
eISSN - 0973-3922
pISSN - 0378-6323
DOI - 10.4103/ijdvl.ijdvl_848_17
Subject(s) - rituximab , medicine , pemphigus , retrospective cohort study , rheumatoid arthritis , prednisolone , prednisone , single center , complete remission , surgery , chemotherapy , immunology , lymphoma
Rituximab is being increasingly used for the treatment of pemphigus. Data derived from single-center studies following a uniform treatment protocol are limited. Effect of demography and disease type on treatment response is poorly characterized.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom